Open Access

Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?

Presentation

About the speaker

Doctor Alok Khorana

Cleveland (United States of America)
1 presentation
0 follower

6 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Konstantinides (Mainz, DE)

Thumbnail

Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.

Speaker: Professor S. Konstantinides (Mainz, DE)

Thumbnail

Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.

Speaker: Professor J. Weitz (Hamilton, CA)

Thumbnail

Access the full session

Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios

Speakers: Doctor A. Khorana, Professor S. Konstantinides, Professor S. Konstantinides, Professor J. Weitz
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Challenges in the diagnosis of HFpEF.

29 August 2021

Open Access

Definition and pathophysiological mechanisms of HFpEF.

29 August 2021

Open Access

Influenza and cardiovascular disease.

27 August 2021

This platform is supported by

logo Novo Nordisk